Follow
Brian Salmons
Brian Salmons
SG Austria/Austrianova Singapore
Verified email at sgaustria.com
Title
Cited by
Cited by
Year
Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression
M Wachinger, A Kleinschmidt, D Winder, N von Pechmann, A Ludvigsen, ...
Journal of General Virology 79 (4), 731-740, 1998
3861998
Targeting of retroviral vectors for gene therapy
B Salmons, WH Gunzburg
Human gene therapy 4 (2), 129-141, 1993
2941993
Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma
M Löhr, A Hoffmeyer, JC Kröger, M Freund, J Hain, A Holle, P Karle, ...
The Lancet 357 (9268), 1591-1592, 2001
2682001
Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: influence of mismatches on quantification
D Klein, P Janda, R Steinborn, M Müller, B Salmons, WH Günzburg
Electrophoresis 20, 291-299, 1999
2071999
Expression of antimicrobial peptides has an antitumour effect in human cells
D Winder, WH Günzburg, V Erfle, B Salmons
Biochemical and Biophysical Research Communications 242 (3), 608-612, 1998
1571998
Development of cellulose sulfate‐based polyelectrolyte complex microcapsules for medical applications
H Dautzenberg, UTE Schuldt, G Grasnick, P Karle, P Müller, M Löhr, ...
Annals of the New York Academy of Sciences 875 (1), 46-63, 1999
1421999
The v‐mos and H‐ras oncogene expression represses glucocorticoid hormone‐dependent transcription from the mouse mammary tumor virus LTR.
R Jaggi, B Salmons, D Muellener, B Groner
The EMBO Journal 5 (10), 2609-2616, 1986
1221986
Factors controlling the expression of mouse mammary tumour virus.
WH Günzburg, B Salmons
Biochemical Journal 283 (Pt 3), 625, 1992
1201992
Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450
M Löhr, P Müller, P Karle, J Stange, S Mitzner, R Jesnowski, H Nizze, ...
Gene Therapy 5 (8), 1070-1078, 1998
1181998
Oncogenic viruses and breast cancer: mouse mammary tumor virus (MMTV), bovine leukemia virus (BLV), human papilloma virus (HPV), and epstein–barr virus (EBV)
JS Lawson, B Salmons, WK Glenn
Frontiers in oncology 8, 1, 2018
1152018
Mouse mammary tumor virus infects human cells
S Indik, WH Günzburg, B Salmons, F Rouault
Cancer research 65 (15), 6651-6659, 2005
1102005
A novel, mouse mammary tumor virus encoded protein with Rev-like properties
S Indik, WH Günzburg, B Salmons, F Rouault
Virology 337 (1), 1-6, 2005
1092005
WPRE-mediated enhancement of gene expression is promoter and cell line specific
R Klein, B Ruttkowski, E Knapp, B Salmons, WH Günzburg, C Hohenadl
Gene 372, 153-161, 2006
1062006
Mouse mammary tumor virus integration site selection in human and mouse genomes
A Faschinger, F Rouault, J Sollner, A Lukas, B Salmons, WH Günzburg, ...
Journal of virology 82 (3), 1360-1367, 2008
1052008
Influence of preassay and sequence variations on viral load determination by a multiplex real-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus
D Klein, CM Leutenegger, C Bahula, P Gold, R Hofmann-Lehmann, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 26 (1), 8-20, 2001
1032001
A mammary-specific promoter directs expression of growth hormone not only to the mammary gland, but also to Bergman glia cells in transgenic mice
WH Günzburg, B Salmons, B Zimmermann, M Müller, V Erfle, G Brem
Molecular Endocrinology 5 (1), 123-133, 1991
971991
Virus vector design in gene therapy
WH Günzburg, B Salmons
Molecular medicine today 1 (9), 410-417, 1995
911995
Current perspectives in the biology of mouse mammary tumour virus
B Salmons, WH Günzburg
Virus research 8 (2), 81-102, 1987
861987
Accurate estimation of transduction efficiency necessitates a multiplex real-time PCR
D Klein, B Bugl, WH Günzburg, B Salmons
Gene therapy 7 (6), 458-463, 2000
852000
Pseudotyped retroviral particles
B Salmons, JG Baumann
US Patent 6,117,681, 2000
802000
The system can't perform the operation now. Try again later.
Articles 1–20